In addition, the prevalence of anti-HCV antibody in the age groups of 18–25, 25–35, 35–45, and 45–55 among the voluntary blood donors were 0.55% (95% CI, 0.29%–0.88%), 0.58% (95% CI, 0.26%–1.03%), 0.68% (95% CI, 0.34%–1.12%), and 0.78% (95% CI, 0.24%–1.63%), respectively, presenting an increasing trend also.
← all excerpts
Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis.
1
—
—